Virt-Advance Prenatal Softgels Recalled Due to API Manufacturer Import Alert
Virtus Pharmaceuticals is recalling Virt-Advance Prenatal/Postnatal Softgels because the active ingredient manufacturer is on an FDA Import Alert.
What this means for you
Cosmetic or documentation issue. No expected health impact, but the manufacturer is correcting the affected products.
Our severity reasoning: The recall is classified as FDA Class III, which the rubric defines as typically resulting in a score of 1 or 2 because it is unlikely to cause adverse health consequences.
Plain-English summary
Virtus Pharmaceuticals OPCO II L is recalling Virt-Advance Prenatal/Postnatal Softgels, a prescription folic acid-containing dietary supplement. The product is packaged in 90-count bottles and is distributed nationwide. The recall involves 2,537 bottles with lot numbers 41505136 (expiration date 5/30/2017) and 41605134 (expiration date 4/30/2018).
The recall was initiated due to Current Good Manufacturing Practice (cGMP) deviations. Specifically, the manufacturer of the Active Pharmaceutical Ingredient (API) is currently on an FDA Import Alert. This classification indicates that the agency has identified potential quality or safety issues with the supplier.
Consumers who have this product should stop using it and contact their healthcare provider or pharmacist for guidance. The recall is classified as Class III by the FDA, which indicates that the product is not likely to cause adverse health consequences.
The recalled product
- Product
- Virt-Advance Prenatal/Postnatal Softgels, Prescription Folic Acid Containing Dietary Supplement, packaged in 90-count bottle, Rx only, Made in Canada, NDC 76439-357-90
- Manufacturer
- VIRTUS PHARMACEUTICALS OPCO II L
- Category
- Drug — Dietary Supplement
- Affected units
- 2,537
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- Lots #: 41505136 Exp. Date 5/30/2017 and 41605134 Exp. date 4/30/2018
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 4 recalled by VIRTUS PHARMACEUTICALS OPCO II L under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 4 products in this recall →Related recalls
Same manufacturer · VIRTUS PHARMACEUTICALS OPCO II L
See all →- LowVirtus Pharmaceuticals Recalls Extra-Virt Plus DHA Prenatal Softgels
FDA (Drugs) · 2017-01-04
- ModerateVirtus Pharmaceuticals Recalls Virt-Select Prenatal Softgels Due to GMP Deviations
FDA (Drugs) · 2017-01-04
- LowVirtPrex Prenatal Tablets Recalled Due to API Manufacturer Import Alert
FDA (Drugs) · 2017-01-04
- SevereVirtus Recalls Hyoscyamine Sulfate Tablets Due to Content Uniformity Failures
FDA (Drugs) · 2016-12-28
- SevereVirtus Recalls Hyoscyamine Sulfate Tablets Due to Potency Failures
FDA (Drugs) · 2016-12-28
Same hazard · cGMP deviation
See all →- HighCinacalcet Tablets Recalled for N-Nitroso Impurity Exceeding Limits
FDA (Drugs) · 2026-07-08
- SevereCinacalcet Tablets Recalled for cGMP Deviations
FDA (Drugs) · 2026-07-08
- ModerateFentanyl Citrate Injectable Solution Recalled for cGMP Deviations
FDA (Drugs) · 2026-05-06
- ModerateIndomethacin Extended-Release Capsules recalled for cGMP deviations
FDA (Drugs) · 2025-06-11
- SevereLubricant Eye Drops Solution recalled due to sterility assurance concerns
FDA (Drugs) · 2025-05-14